Skip to main content
. 2010 Jun 9;14(3):R107. doi: 10.1186/cc9056

Table 1.

Characteristics of the 284 HIV-positive patients admitted to the ICU between 1996 and 2005

Variable Survived the ICU (n = 245) Died in the ICU (n = 39) Odds ratio (95% confidence interval) P value
Age 42.6 (36.4 to 48.6) 41.3(36.1 to 49) 1 (0.9 to 1) 0.9
Males 176 (71.8) 27(69.2) 0.9 (0.4 to 1.8) 0.74
Period of ICU admission
 1996 to 1997 18 (7.3) 6 (15.4) Ref -
 1998 to 2000 63 (25.7) 13 (33.3) 0.62 (0.21 to 1.86) 0.39
 2001 to 2003 79 (32.2) 12 (30.8) 0.46 (0.15 to 1.38) 0.16
 2004 to 2005 85 (34.7) 8 (20.5) 0.28 (0.09 to 0.91) 0.03
Co-morbidities
 COPD 12 (4.9) 3 (7.7) 1.6 (0.4 to 6.1) 0.5
 Hepatic cirrhosis 19 (7.8) 9 (23) 3.6 (1.5 to 8.6) 0.005
 Chronic C hepatitis infection 45 (18.4) 11(28.2) 1.7 (0.8 to 3.8) 0.1
 Chronic B hepatitis infection 41 (16.7) 9 (23.1) 1.5 (0.7 to 3.4) 0.3
 Chronic renal failure 18 (7.3) 1 (2.6) 0.3 (0.04 to 2.6) 0.3
 Kaposi sarcoma 23 (9.4) 9 (23.1) 2.9 (1.2 to 6.8) 0.01
 Psychiatric disorders 77 (31.4) 8 (20.5) 0.56 (0.25 to 1.3) 0.2
 Homeless 22 (9) 4 (10.3) 1.2 (0.4 to 3.6) 0.8
HIV-related characteristics
 Time since HIV diagnosis (months) 70.5 (4 to 146) 88 (13 to 149.5) 1 (0.9 to 1) 0.7
 HIV diagnosis within past 60 days 51 (21.1) 5 (14.3) 0.6 (0.2 to 1.7) 0.3
 CD4+ cell count 96 (23.5 to 289) 65 (32 to 287) 0.9 (0.9 to 1) 0.5
 CD4+ cell count <200 162 (66.2) 27 (68.7) 1.12 (0.51 to 2.5) 0.77
Previous opportunistic infections 121 (49.4) 18 (46.1) 0.9 (0.4 to 1.7) 0.7
 Viral load (× 1,000 log10/ml) 53.8 (0.5 to 252) 28.1 (0 to 10825) 1 0.2
 On HAART at ICU admissiona 125 (51) 25 (64.1) 1.7 (0.8 to 3.4) 0.13
 Viral replication controlled 58 (46.4) 10 (43.5) 0.9 (0.4 to 2.2) 0.8
 Cotrimoxazole prophylaxis 79 (32.2) 15 (38.4) 1.3 (0.6 to 2.6) 0.4
ICU admission
 Direct ICU admission 135 (55.1) 15 (38.5) 0.51 (0.25 to 1.02) 0.05
 Hospital to ICU admission (days) 0 (0 to 2) 1 (0 to 8) 1.05/day (1.01 to 1.08) 0.01
Main reason for ICU admission
 Acute respiratory failure 145 (59.2) 22 (56.4) 0.9 (0.4 to 1.8) 0.7
 Coma 71 (28.9) 20 (51.3) 2.6 (1.3 to 5.1) 0.006
 Sepsisb 48 (19.6) 20 (51.3) 4.3 (2.1 to 8.7) 0.0001
 Shockc 34 (13.9) 25 (64.1) 11.1 (5.2 to 23.4) 0.0001
 Renal failure 32 (13.1) 15 (38.5) 4.2 (2 to 8.8) 0.0002
 Metabolic abnormalities 19 (7.8) 13 (33.3) 5.9 (2.6 to 13.4) 0.0001
 Liver failure 9 (3.7) 14 (35.9) 14.7 (5.8 to 37.3) 0.0001
Definite diagnoses
 Infection 103 (42) 26 (66.7) 2.8 (1.3 to 5.6) 0.005
 Septic shockd 12 (4.9) 20 (51.3) 20.4 (8.7 to 48) 0.0001
 Bacterial pneumonia 84 (34.3) 10 (25.6) 0.7 (0.3 to 1.4) 0.3
 Pneumocystis pneumonia 50 (20.4) 3 (7.7) 0.3 (0.1 to 1.1) 0.07
 Cerebral toxoplasmosis 15 (6.1) 2 (2.6) 0.4 (0.05 to 3.1) 0.4
 Status epilepticus 19 (7.8) 3 (7.7) 1 (0.3 to 3.5) 0.9
 Meningitis 18 (7.3) 2 (5.1) 0.7 (0.1 to 3.1) 0.6
 Cerebral hemorrhage 4 (1.6) 5 (12.8) 8.9 (2.3 to 34.6) 0.002
 Multiple organ failure 5 (2) 24 (61.5) 76.8 (25.7 to 229.7) 0.0001
 Macrophage activation syndrome 10 (4) 6(15.4) 4.27 (1.5 to 12.5) 0.008
Life-supporting procedures
 Mechanical ventilation 86 (35.1) 38 (97.4) 70.2 (9.5 to 521) 0.0001
 Renal replacement therapy 17 (6.4) 14 (35.9) 7.5 (3.3 to 17) 0.0001
 Vasopressors 33 (13.5) 31 (79.5) 24.9 (10.5 to 59) 0.0001
 Duration of life support (days) 0 (0 to 3) 3 (1 to 7.7) 1.07 (1.02 to 1.1) 0.002

Data presented as median (interquartile range) or number (percentage). ICU, intensive care unit; COPD, chronic obstructive pulmonary disease; HAART, highly active antiretroviral therapy. aOn HAART at ICU admission for >30 days. bDefined as clinically or microbiologically documented infection with systemic inflammatory response syndrome. cDefined as systolic arterial pressure <80 mmHg despite adequate fluid resuscitation. dDefined as sepsis-induced hypotension persisting despite adequate fluid resuscitation.